Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Cell Therapeutics, Inc. · Seattle, WA United States ·(NASDAQ (GM): CTIC)

Company Description

501 Elliott Ave. West Ste. 400
Seattle, WA
98119
United States (Map)
Phone: 206-282-7100
Fax: 206-284-6206
Toll Free: 800-215-2355
    View Cell Therapeutics, Inc. Locations On A US MapThis link will open in a new window
    Cell Therapeutics (CTI) is a toxic avenger. The firm creates more effective and less toxic treatments for various forms of cancer. CTI is also developing a number of other cancer-fighting compounds, including paclitaxel poliglumex (Opaxio, formerly branded as Xyotax) for non-small cell lung and ovarian cancers, and pixantrone, another treatment for non-Hodgkin's lymphoma. The company's Systems Medicine subsidiary is working on a potential sarcoma-fighter called brostallicin. It no longer markets any commercial products and instead focuses on research and development projects. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Cell Therapeutics, Inc. Financials

    Company TypePublic - NASDAQ (GM): CTIC

    Headquarters
    Fiscal Year-EndDecember
    2008 Sales (mil.)$11.4
    2008 Employees194

    Cell Therapeutics, Inc. Executives

    16 executives listed for Cell Therapeutics, Inc.'s Seattle, WA location.
    TitleName & BioContact
    ChairmanPhillip NudelmanNetwork
    CEO and DirectorJames BiancoNetwork
    PresidentCraig PhilipsNetwork

    Competition

    Competitive Landscape for Cell Therapeutics, Inc.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Cell Therapeutics, Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!